Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Testosterone increases hair growth and acne in transgender men.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Estrogen alone can lower testosterone in some transfeminine people.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Transgender patients use hair restoration surgery to match their hairline with their gender identity.

Create safe, inclusive choir spaces for transgender singers with supportive language and programming.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.